ClinicalTrials.govpublic full text
LANN-study: Lantus, Amaryl, Novorapid, Novomix Study
diabetes mellitus type ii, diabetes, failing oral treatment, weight gain, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 870250
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.